Segmental arterial mediolysis: a less recognised mesenteric vasculopathy

Santhoshini Saravanan1, Rajoo Ramachandran2, Karthikeyan Palanisamy2

  • 1Radio Diagnosis, Sri Ramachandra Institute of Higher Education and Research (Deemed to be University), Chennai, Tamil Nadu, India santhoshini.saravanan@gmail.com.

BMJ Case Reports
|April 25, 2025
PubMed

Insights

Segmental arterial mediolysis (SAM) is a rare vascular condition affecting abdominal arteries. Accurate diagnosis is vital for effective treatment and improved patient outcomes.

Area of Science:

  • Vascular Medicine
  • Radiology
  • Pathology

Background:

  • Segmental arterial mediolysis (SAM) is a non-immune, non-atherosclerotic, and non-inflammatory arteriopathy.
  • It primarily affects medium-sized visceral arteries such as the coeliac, mesenteric, and renal arteries.

Purpose of the Study:

  • To highlight the diagnostic challenges of SAM.
  • To emphasize the importance of differentiating SAM from other vascular diseases due to distinct treatment and outcomes.
  • To underscore the need for understanding clinical and radiological features for accurate diagnosis and management.

Main Methods:

  • Review of clinical and radiological features of SAM.
  • Comparison with other vascular pathologies.
  • Discussion of diagnostic difficulties, including limitations in histological sampling.

Main Results:

  • SAM presents diagnostic challenges due to overlapping radiological findings with other vascular diseases.
  • Histological sample acquisition can be difficult, further complicating diagnosis.
  • Distinguishing SAM is critical for appropriate therapeutic strategies.

Conclusions:

  • Accurate diagnosis of SAM is essential for effective patient management.
  • Understanding the specific clinical and radiological characteristics of SAM is crucial.
  • Further research may improve diagnostic accuracy and treatment protocols for SAM.